Patagonia Pharmaceuticals is a clinical-stage, specialty pharmaceutical company developing prescription therapies for rare dermatological diseases. Its product pipeline includes candidates for the treatment of congenital ichthyosis, rare neuropathic pain and pruritus, and scleroderma.